Unlike traditional healthy versus disease biomarker studies, researchers cross-referenced human proteomes of almost 60 diseases to identify unique profiles.

WASHINGTON and ZURICH, May 19, 2025 (GLOBE NEWSWIRE) -- SISCAPA Assay Technologies, a global leader in high-sensitivity protein quantitation, and Biognosys, a pioneer in next-generation proteomics, ...

As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...

To explore the latest breakthroughs in proteomics, GEN spoke with five companies at the forefront of proteomic innovation.

Explore how proteomics in drug discovery supports drug target identification, biomarker discovery and the unearthing of safer ...

When confirming antibody concentrations, sizing up proteins, or seeking the perfect formulation for a next-gen biologic, traditional approaches leave researchers tied to the lab bench for way too long ...

Tension has been brewing in the world of nutrition. The subject of the dispute? Protein — or more precisely, protein requirements, and journalists, scientists, government officials, and health ...

Fats and carbohydrates, eat your hearts out—protein is the macronutrient of the moment. Rich people love the stuff. They treat it like ambrosia. Are they onto something? Having protein on your plate ...

The David bar’s breakout success is proof that, in our culture of optimization, one macronutrient is king. But can the protein craze last? Credit...David Chow for The New York Times Supported by By ...